MedPath

A prospective cohort study for prognostic value of LR11 in patients with malignant lymphoma (LR11-ML-study)

Not Applicable
Conditions
Malignant Lymphoma
Registration Number
JPRN-UMIN000013389
Lead Sponsor
Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who could not obtain written consent.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath